Infusion Therapy News and Research

RSS

Pall in-line filters can reduce severe complications, length of hospital stay in PICU

A recently published clinical study on infusion therapy indicates in-line filters from Pall Corporation can reduce severe complications and the length of a patient's stay in the pediatric intensive care unit.

From Pall Corporation 8 May 2012

Infusion Nurses Society to release journal iPad app

Keeping up with the latest research and commentary in infusion nursing just got easier, with the premiere of the new Journal of Infusion Nursing iPad app. The official journal of the Infusion Nurses Society (INS) will showcase the app during the INS 2012 Annual Conference in Las Vegas, April 28- May 3rd. The Journal of Infusion Nursing is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

30 Apr 2012

NYU Langone announces opening of Center for Musculoskeletal Care

NYU Langone Medical Center ushered in the next generation of orthopaedic, rheumatologic and rehabilitative care with the opening of the Center for Musculoskeletal Care (CMC) at 333 East 38th Street in Manhattan last week.

11 Apr 2012

NYU Langone HJD first in the Metro NY area to launch J-tip needle-free anesthetic system

NYU Langone Hospital for Joint Diseases' Center for Children, part of the new Hassenfeld Pediatric Center, is the first pediatric hospital in the Metropolitan New York area to introduce the J-tip needle-free anesthetic system.

24 Feb 2012

Cardinal Health launches infusion room management tool for community rheumatologists

Cardinal Health Specialty Solutions today launched InfusaTrack, a Web-based infusion room management tool that makes it easier for community rheumatology practices to offer in-office infusion therapy services to patients.

7 Jan 2012

New Banner MD Anderson center to deliver unprecedented cancer care in Arizona

Banner MD Anderson Cancer Center, a unique collaboration between Banner Health and The University of Texas MD Anderson Cancer Center, opens today, ushering in a new era of unprecedented cancer care in Arizona.

27 Sep 2011

European infusion therapy device market to reach €533 million by 2017: New report

According to a new report by iData Research, the leading global authority in medical device market research, the European infusion therapy device market, which includes needleless connectors, infusion pumps and intravenous (IV) sets, was valued at an estimated €443 million in 2010.

29 Aug 2011

FDA clears Inhibikase IkT-001 Phase II trial to treat JCV infection in multiple sclerosis patients

Inhibikase Therapeutics, Inc., an emerging leader in infectious disease, announced today that it has received FDA clearance to commence a Phase II proof-of-concept trial for its lead compound IkT-001. IkT-001, a host-directed kinase inhibitor, is intended to clear JC polyomavirus (JCV) infection, the causative agent of Progressive Multifocal Leukoencephalopathy (PML).

17 Aug 2011

CarePoint acquires infusion business of ArTex Medical

Waud Capital Partners announced that its portfolio company, CarePoint Partners, has acquired the infusion business of ArTex Medical, Inc., marking its 13th acquisition in under four years.

20 Jun 2011

Catheter Connections presents DualCap device clinical data against CRBSI at SHEA meeting

In the ongoing fight against costly and potentially fatal catheter related bloodstream infections, landmark clinical data presented at the 21st Annual Scientific Meeting of the Society for Healthcare Epidemiology of America demonstrates that both the exposed end of IV administration sets and catheter luer access valves are colonized by the microbes that cause CRBSI.

4 Apr 2011

CarePoint Partners launches "Got Food?" campaign

CarePoint Partners, one of the largest, fastest growing independent home infusion therapy companies in the United States, launched a food drive today throughout its twenty-one locations in eight states to help the less fortunate in the communities where it operates.

2 Apr 2011

Conflicts in medical management of hemophilia

Hemophilia is a medical disorder that is part of our genetic load as humans. It will never disappear. Therefore, the only way to live with it is to receive adequate medical management. Its effects on those males who have inherited the disorder that affects their blood clotting without treatment includes recurrent hemorrhages (bleeds) into joints as well as internal bleeding. The bleeds are painful, resulting in disuse, disability and crippling. The first signs usually appear in early childhood. A child who suffers a mouth bleed can slowly lose enough blood to result in death.

8 Mar 2011

Apria Healthcare fourth quarter revenues decrease 1.6% to $527.7 million

Apria Healthcare Group Inc., a quality, cost-efficient provider of home healthcare products and services in the United States, today announced its financial results for the quarter and year ended December 31, 2010.

18 Feb 2011

University Hospitals receives $42 million for cancer care

Jane and Lee Seidman have donated $42 million to University Hospitals (UH) the largest gift in the Cleveland-based health system's history. In recognition of this unprecedented generosity, UH is naming the "Jane and Lee Seidman Cancer Center" in their honor.

30 Nov 2010

Bioniche's achievement of fourth milestone in Urocidin Phase III trial triggers $4.0M payment from Endo

Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today announced achievement of a US$4.0 million milestone payment from its development partner, Endo Pharmaceuticals Inc. This milestone is the fourth achieved by Bioniche subsequent to the parties executing their agreement in July, 2009.

18 Nov 2010

Gentiva third quarter total net revenues increase 38% to $387.8 million

Gentiva Health Services, Inc., a leading provider of home health and hospice services, today reported third quarter 2010 results.

9 Nov 2010

Provident launches Principals Fund I with $25 million of committed capital

Provident Healthcare Ventures, LLC is pleased to announce the launch of its inaugural Principals Fund I with $25 million of committed capital. All capital invested in the Fund will be provided by the principals of Provident, affirming their belief that providing early-stage healthcare services companies with crucial resources, such as capital and operating expertise, will significantly increase enterprise value over the life of the investment.

2 Nov 2010

Total Medical Solutions ranks #291 on 2010 Inc. 500/5000 list of fastest-growing private companies

For the second year, Total Medical Solutions (TMS) has made Inc. magazine's list of the 5,000 fastest-growing private companies in the US. The 2010 Inc. 500/5000 is ranked according to percentage revenue growth when comparing 2006 to 2009. TMS saw its revenue grow by 53 percent and ranks as number 291 in its industry category of Health.

9 Sep 2010

American HomePatient announces extension of self-tender offer

American HomePatient, Inc., one of the nation's largest home health care providers, today announced that it is extending its previously announced self-tender offer for all outstanding shares of common stock of the Company at $0.67 per share, until 5:00 P.M., New York City time, Wednesday, September 1, 2010, unless the tender offer is further extended.

26 Aug 2010

Bioniche provides update on Urocidin clinical development program for non-muscle-invasive bladder cancer

Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today provided an update on the clinical development program for its proprietary product for non-muscle-invasive bladder cancer - Urocidin.

20 Aug 2010